--- Page 1 ---
 
Introduced Version
HOUSE BILL No. 1062
_____
DIGEST OF  INTRODUCED B ILL
Citations Affected:  IC 5-10-8-18.5; IC 27-8-5-32; IC 27-13-7-29.
Synopsis:  Coverage for certain cancer prescriptions. Prohibits a state
employee health plan, a policy of accident and sickness insurance, and
a health maintenance organization that provides coverage for advanced,
metastatic cancer and associated conditions from requiring that, before
providing coverage for a prescription drug, the insured fail to
successfully respond to a different prescription drug or prove a history
of failure of a different prescription drug.
Effective:  July 1, 2025.
Pryor
January 8, 2025, read first time and referred to Commi ttee on Insurance.
2025 IN 1062—LS 6455/DI 154


--- Page 2 ---
Introduced
First Reg ular Sessio n of the 124th General A ssem bly (2025)
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
Constitution) is being amended, the text of the existing provision will appear in this style type,
additions will appear in this sty le type, and deletions will appear in this style type.
  Additions: Whenever a new statutory provision is being enacted (or a new constitutional
provision adopted), the text of the new provision will appear in  this  style  type. Also, the
word NEW will appear in that style type in the introductory clause of each SECTION that adds
a new provision to the Indiana Code or the Indiana Constitution.
  Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
between statutes enacted by the 2024 Regular Session of the General Assembly.
HOUSE BILL No. 1062
A BILL FOR AN ACT to amend the Indiana Code concerning
insurance.
Be it enacted by the General Assembly of the State of Indiana:
1 SECTION 1. IC 5-10-8-18.5 IS ADDED TO THE INDIANA CODE
2 AS A NEW SECTION TO READ AS FOLLOWS [EFFECTIVE JULY
3 1, 2025]: Sec. 18.5. (a) This section applies only to a prescription
4 drug that is:
5 (1) consistent with best practices for the treatment of
6 advanced, metastatic cancer or an associated condition;
7 (2) supported by peer reviewed, evidence based literature;
8 and
9 (3) approved by the federal Food and Drug Administration.
10 (b) As used in this section, "advanced, metastatic cancer" means
11 cancer that has spread from the primary or original site of the
12 cancer to nearby tissues, lymph nodes, or other areas or parts of
13 the body.
14 (c) As used in this section, "associated conditions" means the
15 symptoms or side effects associated with advanced, metastatic
16 cancer or its treatment, which would, in the judgment of a health
17 care practitioner, further jeopardize the health of the covered
2025 IN 1062—LS 6455/DI 154


--- Page 3 ---
2
1 individual if left untreated.
2 (d) As used in this section, "covered individual" means an
3 individual entitled to coverage under a state employee health plan.
4 (e) As used in this section, "state employee health plan" refers
5 to the following that provide coverage for prescription drugs:
6 (1) A self-insurance program established under section 7(b) of
7 this chapter.
8 (2) A contract with a prepaid health care delivery plan that is
9 entered into or renewed under section 7(c) of this chapter.
10 (f) A state employee health plan that provides coverage for
11 advanced, metastatic cancer and associated conditions may not
12 require that, before the state employee health plan provides
13 coverage for a prescription drug, the covered individual:
14 (1) fail to successfully respond to a different prescription
15 drug; or
16 (2) prove a history of failure of a different prescription drug.
17 SECTION 2. IC 27-8-5-32 IS ADDED TO THE INDIANA CODE
18 AS A NEW SECTION TO READ AS FOLLOWS [EFFECTIVE JULY
19 1, 2025]: Sec. 32. (a) This section applies only to a prescription drug
20 that is:
21 (1) consistent with best practices for the treatment of
22 advanced, metastatic cancer or an associated condition;
23 (2) supported by peer reviewed, evidence based literature;
24 and
25 (3) approved by the federal Food and Drug Administration.
26 (b) As used in this section, "advanced, metastatic cancer" means
27 cancer that has spread from the primary or original site of the
28 cancer to nearb y tissues, lymph nodes, or other areas or parts of
29 the body.
30 (c) As used in this section, "associated conditions" means the
31 symptoms or side effects associated with advanced, metastatic
32 cancer or its treatment, which would, in the judgment of a health
33 care practitioner, further jeopardize the health of the insured if left
34 untreated.
35 (d) As used in this section, "insured" means an individual who
36 is entitled to coverage under a policy of accident and sickness
37 insurance.
38 (e) As used in this section, "policy of accident and sickness
39 insurance" means a policy of accident and sickness insurance that
40 provides coverage for prescription drugs.
41 (f) A policy of accident and sickness insurance that provides
42 coverage for advanced, metastatic cancer and associated conditions
2025 IN 1062—LS 6455/DI 154


--- Page 4 ---
3
1 may not require that, before the policy of accident and sickness
2 insurance provides coverage for a prescription drug, the insured:
3 (1) fail to successfully respond to a different prescription
4 drug; or
5 (2) prove a history of failure of a different prescription drug.
6 SECTION 3. IC 27-13-7-29 IS ADDED TO THE INDIANA CODE
7 AS A NEW SECTION TO READ AS FOLLOWS [EFFECTIVE JULY
8 1, 2025]: Sec. 29. (a) This section applies only to a prescription drug
9 that is:
10 (1) consistent with best practices for the treatment of
11 advanced, metastatic cancer or an associated condition;
12 (2) supported by peer reviewed, evidence based literature;
13 and
14 (3) approved by the federal Food and Drug Administration.
15 (b) As used in this section, "advanced, metastatic cancer" means
16 cancer that has spread from the primary or original site of the
17 cancer to nearby tissues, lymph nodes, or other areas or parts of
18 the body.
19 (c) As used in this section, "associated conditions" means the
20 symptoms or side effects associated with advanced, metastatic
21 cancer or its treatment, which would, in the judgment of a health
22 care practitioner, further jeopardize the health of the enrollee if
23 left untreated.
24 (d) As used in this section, "group contract" refers to a group
25 contract that provides coverage for prescription drugs.
26 (e) As used in this section, "health maintenance organization"
27 refers to a health maintenance organization that provides coverage
28 for prescription drugs. The term includes the following:
29 (1) A limited service health maintenance organization.
30 (2) A person that administers prescription drug benefits on
31 behalf of a health maintenance organization or a limited
32 service health maintenance organization.
33 (f) As used in this section, "individual contract" refers to an
34 individual contract that provides coverage for prescription drugs.
35 (g) A health maintenance organization that provides coverage
36 under an individual contract or a group contract for advanced,
37 metastatic cancer and associated conditions may not require that,
38 before the health maintenance organization provides coverage for
39 a prescription drug, the enrollee:
40 (1) fail to successfully respond to a different prescription
41 drug; or
42 (2) prove a history of failure of a different prescription drug.
2025 IN 1062—LS 6455/DI 154
